Clinical Trial Update: Paclitaxel and Carboplatin or Temozolomide in Treating Patients With Stage IV Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial comparing paclitaxel plus carboplatin versus temozolomide in stage IV melanoma; the study was terminated and results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Mayo Clinic | Conditions: Melanoma (Skin) | Phase 2 | Status: TERMINATED | Results posted: 2012-03-30